Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Terreno Realty
TRNO
$7.43B
| $3.49M | ﹤0.01% |
61,300
-153,200
| -71% | -$8.6M |
|
1727
Cohen & Steers
CNS
$4.36B
| $3.48M | ﹤0.01% |
53,942
-15,770
| -23% | -$989K |
|
|
ONL
1728
Orion Office REIT
ONL
$164M
| $3.48M | ﹤0.01% |
407,700
+47,200
| +13% | +$431K |
|
1729
Utz Brands
UTZ
$1.26B
| $3.48M | ﹤0.01% |
219,100
+32,400
| +17% | +$537K |
|
1730
First Bancorp
FNLC
$402M
| $3.46M | ﹤0.01% |
115,663
-7,615
| -6% | -$228K |
|
1731
Cemex
CX
$16B
| $3.46M | ﹤0.01% |
854,293
-1,663,100
| -66% | -$6.65M |
|
1732
Fresenius Medical Care
FMS
$12.7B
| $3.44M | ﹤0.01% |
+210,300
| New | +$3.12M |
|
|
PINE
1733
Alpine Income Property Trust
PINE
$348M
| $3.44M | ﹤0.01% |
180,100
+123,022
| +216% | +$2.23M |
|
|
AMNB
1734
DELISTED
American National Bankshares Inc
AMNB
| $3.43M | ﹤0.01% |
92,991
-7,400
| -7% | -$270K |
|
1735
Kamada
KMDA
$437M
| $3.43M | ﹤0.01% |
855,545
-24,800
| -3% | -$109K |
|
1736
Townsquare Media
TSQ
$104M
| $3.43M | ﹤0.01% |
473,252
-54,700
| -10% | -$412K |
|
1737
First Community Bankshares
FCBC
$936M
| $3.43M | ﹤0.01% |
101,094
-7,400
| -7% | -$264K |
|
|
SUP
1738
DELISTED
Superior Industries International
SUP
| $3.42M | ﹤0.01% |
810,009
-91,400
| -10% | -$388K |
|
1739
NETSCOUT
NTCT
$2.88B
| $3.41M | ﹤0.01% |
104,900
+46,600
| +80% | +$1.61M |
|
|
TPIC
1740
DELISTED
TPI Composites
TPIC
| $3.41M | ﹤0.01% |
336,200
-118,000
| -26% | -$1.23M |
|
1741
Zai Lab
ZLAB
$2.91B
| $3.4M | ﹤0.01% |
110,700
+82,000
| +286% | +$2.59M |
|
1742
Cytokinetics
CYTK
$10.3B
| $3.38M | ﹤0.01% |
+73,667
| New | +$3.17M |
|
|
TUP
1743
DELISTED
Tupperware Brands Corporation
TUP
| $3.37M | ﹤0.01% |
814,796
+718,596
| +747% | +$3.85M |
|
1744
TriMas Corp
TRS
$1.4B
| $3.36M | ﹤0.01% |
121,270
-38,600
| -24% | -$1.03M |
|
1745
Beazer Homes USA
BZH
$872M
| $3.36M | ﹤0.01% |
263,428
+192,100
| +269% | +$2.33M |
|
1746
Innovative Solutions & Support
ISSC
$412M
| $3.35M | ﹤0.01% |
407,710
-27,400
| -6% | -$241K |
|
|
MRSN
1747
DELISTED
Mersana Therapeutics
MRSN
| $3.35M | ﹤0.01% |
22,869
-5,084
| -18% | -$859K |
|
1748
Oscar Health
OSCR
$10.1B
| $3.35M | ﹤0.01% |
1,361,399
+97,999
| +8% | +$306K |
|
1749
Allot
ALLT
$383M
| $3.34M | ﹤0.01% |
970,806
-88,800
| -8% | -$333K |
|
1750
LegalZoom.com
LZ
$963M
| $3.33M | ﹤0.01% |
430,942
+373,800
| +654% | +$3.24M |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 524 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 524 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.